# A Double-Blind Study Evaluating Duvelisib in Subjects With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate Alone

> **NCT01851707** · PHASE2 · COMPLETED · sponsor: **SecuraBio** · enrollment: 322 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** IPI-145
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01851707
- **Lead sponsor:** SecuraBio
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2014-12
- **Final completion:** 2015-02
- **Target enrollment:** 322 (ACTUAL)
- **Last updated:** 2021-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01851707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01851707, "A Double-Blind Study Evaluating Duvelisib in Subjects With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate Alone". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01851707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*